世界の獣医用鎮痛剤市場予測 2023年-2029年

【英語タイトル】Global Veterinary Pain Medication Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC01044)・商品コード:LP23DC01044
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥549,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥823,500見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,098,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の獣医用鎮痛剤市場」は、過去の販売実績から2022年の世界の獣医用鎮痛剤の総販売量を検討し、2023年から2029年の予測される獣医用鎮痛剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の獣医用鎮痛剤の市場規模を掲載し、XXX百万米ドル規模の世界の獣医用鎮痛剤市場の詳細な分析を提供します。本インサイトレポートは、世界の獣医用鎮痛剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の獣医用鎮痛剤市場における各社の独自のポジションをより深く理解するために、獣医用鎮痛剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の獣医用鎮痛剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。獣医用鎮痛剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。獣医用鎮痛剤の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。獣医用鎮痛剤のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

獣医用鎮痛剤の世界主要メーカーとしては、Boehringer Ingelheim、 Elanco、 Zoetis、 Baxter、 Halyard、 Endo International、 Forest Laboratories、 Medtronic、 Bayer Pharma AG、 Ceva Sante Animale、 Ringpu Bio-technology、 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.、 Norbrook Laboratories、 Merck & Co、 Bostonscientific、 Lilly、 Pfizer、 Harbin Bolai Pharmaceutical Co., Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の獣医用鎮痛剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では獣医用鎮痛剤市場をセグメンテーションし、種類別 (注射薬、内服薬)、用途別 (動物病院、動物診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:注射薬、内服薬

・用途別区分:動物病院、動物診療所、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の獣医用鎮痛剤市場の10年間の市場状況・展望は?
・世界および地域別に見た獣医用鎮痛剤市場成長の要因は何か?
・獣医用鎮痛剤の市場機会はエンドマーケットの規模によってどのように変化するのか?
・獣医用鎮痛剤のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:獣医用鎮痛剤の年間販売量2018-2029、地域別現状・将来分析
・獣医用鎮痛剤の種類別セグメント:注射薬、内服薬
・獣医用鎮痛剤の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・獣医用鎮痛剤の用途別セグメント:動物病院、動物診療所、その他
・獣医用鎮痛剤の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の獣医用鎮痛剤市場
・企業別のグローバル獣医用鎮痛剤市場データ:2018-2023年の年間販売量、市場シェア
・企業別の獣医用鎮痛剤の年間売上:2018-2023年の売上、市場シェア
・企業別の獣医用鎮痛剤販売価格
・主要企業の獣医用鎮痛剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

獣医用鎮痛剤の地域別レビュー
・地域別の獣医用鎮痛剤市場規模2018-2023:年間販売量、売上
・主要国別の獣医用鎮痛剤市場規模2018-2023:年間販売量、売上
・南北アメリカの獣医用鎮痛剤販売の成長
・アジア太平洋の獣医用鎮痛剤販売の成長
・ヨーロッパの獣医用鎮痛剤販売の成長
・中東・アフリカの獣医用鎮痛剤販売の成長

南北アメリカ市場
・南北アメリカの国別の獣医用鎮痛剤販売量、売上(2018-2023)
・南北アメリカの獣医用鎮痛剤の種類別販売量
・南北アメリカの獣医用鎮痛剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の獣医用鎮痛剤販売量、売上(2018-2023)
・アジア太平洋の獣医用鎮痛剤の種類別販売量
・アジア太平洋の獣医用鎮痛剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の獣医用鎮痛剤販売量、売上(2018-2023)
・ヨーロッパの獣医用鎮痛剤の種類別販売量
・ヨーロッパの獣医用鎮痛剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の獣医用鎮痛剤販売量、売上(2018-2023)
・中東・アフリカの獣医用鎮痛剤の種類別販売量
・中東・アフリカの獣医用鎮痛剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・獣医用鎮痛剤の製造コスト構造分析
・獣医用鎮痛剤の製造プロセス分析
・獣医用鎮痛剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・獣医用鎮痛剤の主要なグローバル販売業者
・獣医用鎮痛剤の主要なグローバル顧客

地域別の獣医用鎮痛剤市場予測レビュー
・地域別の獣医用鎮痛剤市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・獣医用鎮痛剤の種類別市場規模予測
・獣医用鎮痛剤の用途別市場規模予測

主要企業分析
Boehringer Ingelheim、 Elanco、 Zoetis、 Baxter、 Halyard、 Endo International、 Forest Laboratories、 Medtronic、 Bayer Pharma AG、 Ceva Sante Animale、 Ringpu Bio-technology、 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.、 Norbrook Laboratories、 Merck & Co、 Bostonscientific、 Lilly、 Pfizer、 Harbin Bolai Pharmaceutical Co., Ltd.
・企業情報
・獣医用鎮痛剤製品
・獣医用鎮痛剤販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Veterinary Pain Medication market size is projected to grow from US$ 4535.2 million in 2022 to US$ 7064 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.
United States market for Veterinary Pain Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Veterinary Pain Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Veterinary Pain Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Veterinary Pain Medication players cover Boehringer Ingelheim, Elanco, Zoetis, Baxter, Halyard, Endo International, Forest Laboratories, Medtronic and Bayer Pharma AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Veterinary Pain Medication Industry Forecast” looks at past sales and reviews total world Veterinary Pain Medication sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Pain Medication sales for 2023 through 2029. With Veterinary Pain Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Pain Medication industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Pain Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Pain Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Pain Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Pain Medication and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Pain Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Pain Medication market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Injection Medicines
Oral Medicines
Segmentation by application
Veterinary Hospitals
Veterinary Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Elanco
Zoetis
Baxter
Halyard
Endo International
Forest Laboratories
Medtronic
Bayer Pharma AG
Ceva Sante Animale
Ringpu Bio-technology
Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
Norbrook Laboratories
Merck & Co
Bostonscientific
Lilly
Pfizer
Harbin Bolai Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Pain Medication market?
What factors are driving Veterinary Pain Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Pain Medication market opportunities vary by end market size?
How does Veterinary Pain Medication break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Pain Medication Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary Pain Medication by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary Pain Medication by Country/Region, 2018, 2022 & 2029
2.2 Veterinary Pain Medication Segment by Type
2.2.1 Injection Medicines
2.2.2 Oral Medicines
2.3 Veterinary Pain Medication Sales by Type
2.3.1 Global Veterinary Pain Medication Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary Pain Medication Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary Pain Medication Sale Price by Type (2018-2023)
2.4 Veterinary Pain Medication Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Others
2.5 Veterinary Pain Medication Sales by Application
2.5.1 Global Veterinary Pain Medication Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary Pain Medication Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary Pain Medication Sale Price by Application (2018-2023)
3 Global Veterinary Pain Medication by Company
3.1 Global Veterinary Pain Medication Breakdown Data by Company
3.1.1 Global Veterinary Pain Medication Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary Pain Medication Sales Market Share by Company (2018-2023)
3.2 Global Veterinary Pain Medication Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary Pain Medication Revenue by Company (2018-2023)
3.2.2 Global Veterinary Pain Medication Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary Pain Medication Sale Price by Company
3.4 Key Manufacturers Veterinary Pain Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Pain Medication Product Location Distribution
3.4.2 Players Veterinary Pain Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary Pain Medication by Geographic Region
4.1 World Historic Veterinary Pain Medication Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary Pain Medication Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary Pain Medication Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary Pain Medication Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary Pain Medication Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary Pain Medication Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary Pain Medication Sales Growth
4.4 APAC Veterinary Pain Medication Sales Growth
4.5 Europe Veterinary Pain Medication Sales Growth
4.6 Middle East & Africa Veterinary Pain Medication Sales Growth
5 Americas
5.1 Americas Veterinary Pain Medication Sales by Country
5.1.1 Americas Veterinary Pain Medication Sales by Country (2018-2023)
5.1.2 Americas Veterinary Pain Medication Revenue by Country (2018-2023)
5.2 Americas Veterinary Pain Medication Sales by Type
5.3 Americas Veterinary Pain Medication Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Pain Medication Sales by Region
6.1.1 APAC Veterinary Pain Medication Sales by Region (2018-2023)
6.1.2 APAC Veterinary Pain Medication Revenue by Region (2018-2023)
6.2 APAC Veterinary Pain Medication Sales by Type
6.3 APAC Veterinary Pain Medication Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary Pain Medication by Country
7.1.1 Europe Veterinary Pain Medication Sales by Country (2018-2023)
7.1.2 Europe Veterinary Pain Medication Revenue by Country (2018-2023)
7.2 Europe Veterinary Pain Medication Sales by Type
7.3 Europe Veterinary Pain Medication Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Pain Medication by Country
8.1.1 Middle East & Africa Veterinary Pain Medication Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary Pain Medication Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary Pain Medication Sales by Type
8.3 Middle East & Africa Veterinary Pain Medication Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Pain Medication
10.3 Manufacturing Process Analysis of Veterinary Pain Medication
10.4 Industry Chain Structure of Veterinary Pain Medication
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Pain Medication Distributors
11.3 Veterinary Pain Medication Customer
12 World Forecast Review for Veterinary Pain Medication by Geographic Region
12.1 Global Veterinary Pain Medication Market Size Forecast by Region
12.1.1 Global Veterinary Pain Medication Forecast by Region (2024-2029)
12.1.2 Global Veterinary Pain Medication Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Pain Medication Forecast by Type
12.7 Global Veterinary Pain Medication Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Veterinary Pain Medication Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Veterinary Pain Medication Product Portfolios and Specifications
13.2.3 Elanco Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Veterinary Pain Medication Product Portfolios and Specifications
13.3.3 Zoetis Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Veterinary Pain Medication Product Portfolios and Specifications
13.4.3 Baxter Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Halyard
13.5.1 Halyard Company Information
13.5.2 Halyard Veterinary Pain Medication Product Portfolios and Specifications
13.5.3 Halyard Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Halyard Main Business Overview
13.5.5 Halyard Latest Developments
13.6 Endo International
13.6.1 Endo International Company Information
13.6.2 Endo International Veterinary Pain Medication Product Portfolios and Specifications
13.6.3 Endo International Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Endo International Main Business Overview
13.6.5 Endo International Latest Developments
13.7 Forest Laboratories
13.7.1 Forest Laboratories Company Information
13.7.2 Forest Laboratories Veterinary Pain Medication Product Portfolios and Specifications
13.7.3 Forest Laboratories Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Forest Laboratories Main Business Overview
13.7.5 Forest Laboratories Latest Developments
13.8 Medtronic
13.8.1 Medtronic Company Information
13.8.2 Medtronic Veterinary Pain Medication Product Portfolios and Specifications
13.8.3 Medtronic Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medtronic Main Business Overview
13.8.5 Medtronic Latest Developments
13.9 Bayer Pharma AG
13.9.1 Bayer Pharma AG Company Information
13.9.2 Bayer Pharma AG Veterinary Pain Medication Product Portfolios and Specifications
13.9.3 Bayer Pharma AG Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bayer Pharma AG Main Business Overview
13.9.5 Bayer Pharma AG Latest Developments
13.10 Ceva Sante Animale
13.10.1 Ceva Sante Animale Company Information
13.10.2 Ceva Sante Animale Veterinary Pain Medication Product Portfolios and Specifications
13.10.3 Ceva Sante Animale Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ceva Sante Animale Main Business Overview
13.10.5 Ceva Sante Animale Latest Developments
13.11 Ringpu Bio-technology
13.11.1 Ringpu Bio-technology Company Information
13.11.2 Ringpu Bio-technology Veterinary Pain Medication Product Portfolios and Specifications
13.11.3 Ringpu Bio-technology Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Ringpu Bio-technology Main Business Overview
13.11.5 Ringpu Bio-technology Latest Developments
13.12 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
13.12.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information
13.12.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolios and Specifications
13.12.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Latest Developments
13.13 Norbrook Laboratories
13.13.1 Norbrook Laboratories Company Information
13.13.2 Norbrook Laboratories Veterinary Pain Medication Product Portfolios and Specifications
13.13.3 Norbrook Laboratories Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Norbrook Laboratories Main Business Overview
13.13.5 Norbrook Laboratories Latest Developments
13.14 Merck & Co
13.14.1 Merck & Co Company Information
13.14.2 Merck & Co Veterinary Pain Medication Product Portfolios and Specifications
13.14.3 Merck & Co Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Merck & Co Main Business Overview
13.14.5 Merck & Co Latest Developments
13.15 Bostonscientific
13.15.1 Bostonscientific Company Information
13.15.2 Bostonscientific Veterinary Pain Medication Product Portfolios and Specifications
13.15.3 Bostonscientific Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Bostonscientific Main Business Overview
13.15.5 Bostonscientific Latest Developments
13.16 Lilly
13.16.1 Lilly Company Information
13.16.2 Lilly Veterinary Pain Medication Product Portfolios and Specifications
13.16.3 Lilly Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Lilly Main Business Overview
13.16.5 Lilly Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Veterinary Pain Medication Product Portfolios and Specifications
13.17.3 Pfizer Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
13.18 Harbin Bolai Pharmaceutical Co., Ltd.
13.18.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information
13.18.2 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolios and Specifications
13.18.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Harbin Bolai Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Harbin Bolai Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Veterinary Pain Medication Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Veterinary Pain Medication Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection Medicines
Table 4. Major Players of Oral Medicines
Table 5. Global Veterinary Pain Medication Sales by Type (2018-2023) & (K Units)
Table 6. Global Veterinary Pain Medication Sales Market Share by Type (2018-2023)
Table 7. Global Veterinary Pain Medication Revenue by Type (2018-2023) & ($ million)
Table 8. Global Veterinary Pain Medication Revenue Market Share by Type (2018-2023)
Table 9. Global Veterinary Pain Medication Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Veterinary Pain Medication Sales by Application (2018-2023) & (K Units)
Table 11. Global Veterinary Pain Medication Sales Market Share by Application (2018-2023)
Table 12. Global Veterinary Pain Medication Revenue by Application (2018-2023)
Table 13. Global Veterinary Pain Medication Revenue Market Share by Application (2018-2023)
Table 14. Global Veterinary Pain Medication Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Veterinary Pain Medication Sales by Company (2018-2023) & (K Units)
Table 16. Global Veterinary Pain Medication Sales Market Share by Company (2018-2023)
Table 17. Global Veterinary Pain Medication Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Veterinary Pain Medication Revenue Market Share by Company (2018-2023)
Table 19. Global Veterinary Pain Medication Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Veterinary Pain Medication Producing Area Distribution and Sales Area
Table 21. Players Veterinary Pain Medication Products Offered
Table 22. Veterinary Pain Medication Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Veterinary Pain Medication Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Veterinary Pain Medication Sales Market Share Geographic Region (2018-2023)
Table 27. Global Veterinary Pain Medication Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Veterinary Pain Medication Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Veterinary Pain Medication Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Veterinary Pain Medication Sales Market Share by Country/Region (2018-2023)
Table 31. Global Veterinary Pain Medication Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Veterinary Pain Medication Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Veterinary Pain Medication Sales by Country (2018-2023) & (K Units)
Table 34. Americas Veterinary Pain Medication Sales Market Share by Country (2018-2023)
Table 35. Americas Veterinary Pain Medication Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Veterinary Pain Medication Revenue Market Share by Country (2018-2023)
Table 37. Americas Veterinary Pain Medication Sales by Type (2018-2023) & (K Units)
Table 38. Americas Veterinary Pain Medication Sales by Application (2018-2023) & (K Units)
Table 39. APAC Veterinary Pain Medication Sales by Region (2018-2023) & (K Units)
Table 40. APAC Veterinary Pain Medication Sales Market Share by Region (2018-2023)
Table 41. APAC Veterinary Pain Medication Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Veterinary Pain Medication Revenue Market Share by Region (2018-2023)
Table 43. APAC Veterinary Pain Medication Sales by Type (2018-2023) & (K Units)
Table 44. APAC Veterinary Pain Medication Sales by Application (2018-2023) & (K Units)
Table 45. Europe Veterinary Pain Medication Sales by Country (2018-2023) & (K Units)
Table 46. Europe Veterinary Pain Medication Sales Market Share by Country (2018-2023)
Table 47. Europe Veterinary Pain Medication Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Veterinary Pain Medication Revenue Market Share by Country (2018-2023)
Table 49. Europe Veterinary Pain Medication Sales by Type (2018-2023) & (K Units)
Table 50. Europe Veterinary Pain Medication Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Veterinary Pain Medication Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Veterinary Pain Medication Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Veterinary Pain Medication Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Veterinary Pain Medication Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Veterinary Pain Medication Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Veterinary Pain Medication Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Veterinary Pain Medication
Table 58. Key Market Challenges & Risks of Veterinary Pain Medication
Table 59. Key Industry Trends of Veterinary Pain Medication
Table 60. Veterinary Pain Medication Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Veterinary Pain Medication Distributors List
Table 63. Veterinary Pain Medication Customer List
Table 64. Global Veterinary Pain Medication Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Veterinary Pain Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Veterinary Pain Medication Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Veterinary Pain Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Veterinary Pain Medication Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Veterinary Pain Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Veterinary Pain Medication Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Veterinary Pain Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Veterinary Pain Medication Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Veterinary Pain Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Veterinary Pain Medication Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Veterinary Pain Medication Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Veterinary Pain Medication Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Veterinary Pain Medication Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Boehringer Ingelheim Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Veterinary Pain Medication Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Elanco Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 84. Elanco Veterinary Pain Medication Product Portfolios and Specifications
Table 85. Elanco Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Elanco Main Business
Table 87. Elanco Latest Developments
Table 88. Zoetis Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoetis Veterinary Pain Medication Product Portfolios and Specifications
Table 90. Zoetis Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Zoetis Main Business
Table 92. Zoetis Latest Developments
Table 93. Baxter Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Veterinary Pain Medication Product Portfolios and Specifications
Table 95. Baxter Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Baxter Main Business
Table 97. Baxter Latest Developments
Table 98. Halyard Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 99. Halyard Veterinary Pain Medication Product Portfolios and Specifications
Table 100. Halyard Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Halyard Main Business
Table 102. Halyard Latest Developments
Table 103. Endo International Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 104. Endo International Veterinary Pain Medication Product Portfolios and Specifications
Table 105. Endo International Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Endo International Main Business
Table 107. Endo International Latest Developments
Table 108. Forest Laboratories Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 109. Forest Laboratories Veterinary Pain Medication Product Portfolios and Specifications
Table 110. Forest Laboratories Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Forest Laboratories Main Business
Table 112. Forest Laboratories Latest Developments
Table 113. Medtronic Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 114. Medtronic Veterinary Pain Medication Product Portfolios and Specifications
Table 115. Medtronic Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Medtronic Main Business
Table 117. Medtronic Latest Developments
Table 118. Bayer Pharma AG Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 119. Bayer Pharma AG Veterinary Pain Medication Product Portfolios and Specifications
Table 120. Bayer Pharma AG Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Bayer Pharma AG Main Business
Table 122. Bayer Pharma AG Latest Developments
Table 123. Ceva Sante Animale Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 124. Ceva Sante Animale Veterinary Pain Medication Product Portfolios and Specifications
Table 125. Ceva Sante Animale Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Ceva Sante Animale Main Business
Table 127. Ceva Sante Animale Latest Developments
Table 128. Ringpu Bio-technology Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 129. Ringpu Bio-technology Veterinary Pain Medication Product Portfolios and Specifications
Table 130. Ringpu Bio-technology Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Ringpu Bio-technology Main Business
Table 132. Ringpu Bio-technology Latest Developments
Table 133. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 134. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolios and Specifications
Table 135. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Main Business
Table 137. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Latest Developments
Table 138. Norbrook Laboratories Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 139. Norbrook Laboratories Veterinary Pain Medication Product Portfolios and Specifications
Table 140. Norbrook Laboratories Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Norbrook Laboratories Main Business
Table 142. Norbrook Laboratories Latest Developments
Table 143. Merck & Co Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 144. Merck & Co Veterinary Pain Medication Product Portfolios and Specifications
Table 145. Merck & Co Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Merck & Co Main Business
Table 147. Merck & Co Latest Developments
Table 148. Bostonscientific Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 149. Bostonscientific Veterinary Pain Medication Product Portfolios and Specifications
Table 150. Bostonscientific Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Bostonscientific Main Business
Table 152. Bostonscientific Latest Developments
Table 153. Lilly Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 154. Lilly Veterinary Pain Medication Product Portfolios and Specifications
Table 155. Lilly Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Lilly Main Business
Table 157. Lilly Latest Developments
Table 158. Pfizer Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 159. Pfizer Veterinary Pain Medication Product Portfolios and Specifications
Table 160. Pfizer Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Pfizer Main Business
Table 162. Pfizer Latest Developments
Table 163. Harbin Bolai Pharmaceutical Co., Ltd. Basic Information, Veterinary Pain Medication Manufacturing Base, Sales Area and Its Competitors
Table 164. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolios and Specifications
Table 165. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Harbin Bolai Pharmaceutical Co., Ltd. Main Business
Table 167. Harbin Bolai Pharmaceutical Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Veterinary Pain Medication
Figure 2. Veterinary Pain Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Pain Medication Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Veterinary Pain Medication Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Veterinary Pain Medication Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection Medicines
Figure 10. Product Picture of Oral Medicines
Figure 11. Global Veterinary Pain Medication Sales Market Share by Type in 2022
Figure 12. Global Veterinary Pain Medication Revenue Market Share by Type (2018-2023)
Figure 13. Veterinary Pain Medication Consumed in Veterinary Hospitals
Figure 14. Global Veterinary Pain Medication Market: Veterinary Hospitals (2018-2023) & (K Units)
Figure 15. Veterinary Pain Medication Consumed in Veterinary Clinics
Figure 16. Global Veterinary Pain Medication Market: Veterinary Clinics (2018-2023) & (K Units)
Figure 17. Veterinary Pain Medication Consumed in Others
Figure 18. Global Veterinary Pain Medication Market: Others (2018-2023) & (K Units)
Figure 19. Global Veterinary Pain Medication Sales Market Share by Application (2022)
Figure 20. Global Veterinary Pain Medication Revenue Market Share by Application in 2022
Figure 21. Veterinary Pain Medication Sales Market by Company in 2022 (K Units)
Figure 22. Global Veterinary Pain Medication Sales Market Share by Company in 2022
Figure 23. Veterinary Pain Medication Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Veterinary Pain Medication Revenue Market Share by Company in 2022
Figure 25. Global Veterinary Pain Medication Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Veterinary Pain Medication Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Veterinary Pain Medication Sales 2018-2023 (K Units)
Figure 28. Americas Veterinary Pain Medication Revenue 2018-2023 ($ Millions)
Figure 29. APAC Veterinary Pain Medication Sales 2018-2023 (K Units)
Figure 30. APAC Veterinary Pain Medication Revenue 2018-2023 ($ Millions)
Figure 31. Europe Veterinary Pain Medication Sales 2018-2023 (K Units)
Figure 32. Europe Veterinary Pain Medication Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Veterinary Pain Medication Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Veterinary Pain Medication Revenue 2018-2023 ($ Millions)
Figure 35. Americas Veterinary Pain Medication Sales Market Share by Country in 2022
Figure 36. Americas Veterinary Pain Medication Revenue Market Share by Country in 2022
Figure 37. Americas Veterinary Pain Medication Sales Market Share by Type (2018-2023)
Figure 38. Americas Veterinary Pain Medication Sales Market Share by Application (2018-2023)
Figure 39. United States Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Veterinary Pain Medication Sales Market Share by Region in 2022
Figure 44. APAC Veterinary Pain Medication Revenue Market Share by Regions in 2022
Figure 45. APAC Veterinary Pain Medication Sales Market Share by Type (2018-2023)
Figure 46. APAC Veterinary Pain Medication Sales Market Share by Application (2018-2023)
Figure 47. China Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Veterinary Pain Medication Sales Market Share by Country in 2022
Figure 55. Europe Veterinary Pain Medication Revenue Market Share by Country in 2022
Figure 56. Europe Veterinary Pain Medication Sales Market Share by Type (2018-2023)
Figure 57. Europe Veterinary Pain Medication Sales Market Share by Application (2018-2023)
Figure 58. Germany Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Veterinary Pain Medication Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Veterinary Pain Medication Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Veterinary Pain Medication Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Veterinary Pain Medication Sales Market Share by Application (2018-2023)
Figure 67. Egypt Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Veterinary Pain Medication Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Veterinary Pain Medication in 2022
Figure 73. Manufacturing Process Analysis of Veterinary Pain Medication
Figure 74. Industry Chain Structure of Veterinary Pain Medication
Figure 75. Channels of Distribution
Figure 76. Global Veterinary Pain Medication Sales Market Forecast by Region (2024-2029)
Figure 77. Global Veterinary Pain Medication Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Veterinary Pain Medication Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Veterinary Pain Medication Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Veterinary Pain Medication Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Veterinary Pain Medication Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の獣医用鎮痛剤市場予測 2023年-2029年] (コード:LP23DC01044)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の獣医用鎮痛剤市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆